MiMedx Group News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.03.24	TELA Bio Announces Sale Of Distribution Rights Related To NIVIS Fibrillar Collagen Pack (RTTNews)
22.01.24	EQS-News: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages MiMedx Group, Inc. Investors to Inquire About Securities Class Action Investigation - MDXG (EQS Group)
31.12.23	MiMedx Receives FDA Warning Letter On Axiofill Production (RTTNews)
09.01.23	MIMEDX Group Backs Q4, FY22 Outlook (RTTNews)
03.01.23	MiMedx Appoints Ricci Whitlow As COO (RTTNews)
14.06.22	Prescience Point Capital Management Says MiMedx Shareholders Have Spoken: Voiced Their Desire For Change (PR Newswire)
07.06.22	Prescience Point Capital Management Calls On MiMedx Group to Immediately Release Preliminary Voting Results of its Annual Meeting (PR Newswire)
31.05.22	Prescience Point Capital Management Releases Presentation Detailing Board And Management Failures at MiMedx Group (PR Newswire)
18.05.22	Prescience Point Capital Management Calls on MiMedx to Confirm the Company Has Received Letters of Serious Concern from other Shareholders (PR Newswire)
06.05.22	Prescience Point Capital Management Issues Open Letter to Shareholders of MiMedx Group (PR Newswire)
16.03.22	WoundGenex Partners with MIMEDX to Launch Premier Graft Program to Wound Care Providers Nationwide (PR Newswire)
13.09.21	MiMedx: Phase 3 PF Study Fails To Meet Primary Endpoint; To Pursue Phase 3 KOA Confirmatory Studies (RTTNews)
27.08.21	MiMedx To Report Key Data This Summer (RTTNews)
31.05.19	5 Top Gainers In Pharma Sector (BCRX, NOVN, TOCA...) (RTTNews)
07.12.18	No Respite For MiMedx, CNAT Fails NASH Trial, NDRA On Watch (RTTNews)
20.11.18	AKER Mulls Foray Into Cannabis, AXSM Awaits ASCEND Data, MRUS Abuzz (RTTNews)
09.11.18	MDXG Delisted, ENDP Boosts Outlook, AKAO Hits New Low, ReShape Deflated (RTTNews)
20.07.18	ACIU Back In Focus, MDXG Works To Undo Past Wrongs, AVEO To Report Data In Q4 (RTTNews)
02.07.18	Scandal Claims Top Brass At MiMedx (RTTNews)
08.06.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of MiMedx Group, Inc. (MDXG) (PR Newswire)
07.06.18	MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress (PR Newswire)
07.06.18	MiMedx to restate certain historical financial statements (PR Newswire)
24.05.18	FDA Nod For AVGR, EOLS Is All Smiles, GERN Up 30% In 3 Days, IMMP On Watch (RTTNews)
18.05.18	MiMedx Receives NASDAQ Notice of Late Form 10-Q Filing (PR Newswire)
10.05.18	MiMedx To Participate In The Bank of America Merrill Lynch Healthcare Conference On May 16, 2018 (PR Newswire)
26.04.18	MiMedx Reports Unreviewed First Quarter Revenue Exceeded Upper End Of Its Guidance (PR Newswire)
26.04.18	EYPT Up 98% This Month, USNA In Good Health, MDXG To Report Q1 Results (RTTNews)
24.04.18	Lifshitz & Miller LLP Announces Investigation of Cancer Genetics, Inc., Colony Northstar, Inc., Pacific Commerce Bancorp, MiMedx Group, Inc., Sorrento Therapeutics, Inc., TrueCar, Inc. (PR Newswire)
23.04.18	MiMedx Will Host Its First Quarter Shareholder Conference Call On Thursday, April 26, 2018 (PR Newswire)
23.04.18	MiMedx to Highlight Efficacy of Its Allografts in Presentations at SAWC Spring Conference (PR Newswire)
28.03.18	MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The Knee (PR Newswire)
26.03.18	MiMedx To Participate In The Needham Healthcare Conference (PR Newswire)
26.03.18	MiMedx Reports Positive Pain And Foot Function Results From Phase 2B Clinical Trial Of AmnioFix® Injectable In The Treatment Of Plantar Fasciitis (PR Newswire)
21.03.18	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MiMedx Group, Inc. of Class Action Lawsuit and Upcoming Deadline -- MDXG (PR Newswire)
16.03.18	MIMEDX GROUP LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In MiMedx Group, Inc. To Contact The Firm (PR Newswire)
15.03.18	MiMedx Announces Expectation to Exceed the $92 Million Top End of First Quarter Revenue Guidance (PR Newswire)
12.03.18	SVRA Disappoints, SNY/REGN's Praluent Price To Be Cut, OBSV On Watch (RTTNews)
09.03.18	AmnioFix® Injectable Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the FDA for the Treatment of Osteoarthritis of the Knee (PR Newswire)
07.03.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against MiMedx Group, Inc. (MDXG) & Lead Plaintiff Deadline: April 25, 2018 (PR Newswire)
02.03.18	MiMedx Receives Notice of Filing Delinquency from NASDAQ (PR Newswire)
24.02.18	Block & Leviton LLP Announces It Has Filed A Class Action Against MiMedx Group, Inc. (MDXG) (PR Newswire)
23.02.18	MiMedx: A Different Kind Of Graft? (RTTNews)
22.02.18	Scott+Scott, Attorneys at Law, LLP Announces Investigation into MiMedx Group Inc. (MDXG) (PR Newswire)
21.02.18	MiMedx to Host Conference Call on February 23, 2018 at 10:30 AM Eastern Time (PR Newswire)
21.02.18	MiMedx Group, Inc. Shareholder Alert -- MDXG Stock Drops Significantly -- Kehoe Law Firm, P.C. Investigating (PR Newswire)
20.02.18	RM LAW Announces Investigation of MiMedx Group, Inc. (PR Newswire)
20.02.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG (PR Newswire)
20.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of MiMedx Group, Inc. (MDXG) (PR Newswire)
20.02.18	MIMEDX GROUP INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In MiMedx Group, Inc. To Contact The Firm (PR Newswire)
20.02.18	Wolf Popper LLP Announces Investigation on Behalf of Investors in MiMedx Group, Inc. (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu MiMedx Group Inc

Aktien Top/Flop

Meistgelesene Nachrichten